Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$527.67 +1.48 (+0.28%)
At close: Sep 28, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Non-Current Debt (2009 - 2018)

Updated

Vertex Pharmaceuticals (VRTX) recorded Non-Current Debt of -$140,000 in Q4 2014.

Analysis

Vertex Pharmaceuticals (VRTX) Non-Current Debt (2009 - 2018) Analysis & Trends

For FY2014, Vertex Pharmaceuticals reported Non-Current Debt of $294.24 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 37.34 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 62.48 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -108.00 Mn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn 42.09 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 561.89 Mn
Sep 30, 2018 561.39 Mn
Jun 30, 2018 562.65 Mn
Mar 31, 2018 561.30 Mn
Dec 31, 2017 563.41 Mn
Sep 30, 2017 547.05 Mn
Jun 30, 2017 525.02 Mn
Mar 31, 2017 498.78 Mn
Dec 31, 2016 486.36 Mn
Sep 30, 2016 473.07 Mn
Jun 30, 2016 472.37 Mn
Mar 31, 2016 472.49 Mn
Dec 31, 2015 472.61 Mn
Sep 30, 2015 472.72 Mn
Jun 30, 2015 472.83 Mn
Mar 31, 2015 472.97 Mn
Dec 31, 2014 473.07 Mn
Sep 30, 2014 473.17 Mn
Jun 30, 2014 473.27 Mn
Mar 31, 2014 473.36 Mn
API Access

Vertex Pharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=VRTX&period=max&api_key=YOUR_API_KEY